Cargando…

Analysis of clinical prognosis in patients with non-hepatic hyperammonemia

The aim of this study was to evaluate the association of non-hepatic hyperammonemia (NHH) with the prognosis of critically ill patients with NHH. According to the serum ammonia level, the patients with NHH (n = 498) were retrieved by us. The risk factors of the mortality with NHH patients were inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yun, Zhou, Qi, Song, Jian-Nan, Chen, Xue-Zhao, Zhang, Xi-Zhe, Sun, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837986/
https://www.ncbi.nlm.nih.gov/pubmed/33546031
http://dx.doi.org/10.1097/MD.0000000000024157
_version_ 1783643070138417152
author Li, Yun
Zhou, Qi
Song, Jian-Nan
Chen, Xue-Zhao
Zhang, Xi-Zhe
Sun, Yi
author_facet Li, Yun
Zhou, Qi
Song, Jian-Nan
Chen, Xue-Zhao
Zhang, Xi-Zhe
Sun, Yi
author_sort Li, Yun
collection PubMed
description The aim of this study was to evaluate the association of non-hepatic hyperammonemia (NHH) with the prognosis of critically ill patients with NHH. According to the serum ammonia level, the patients with NHH (n = 498) were retrieved by us. The risk factors of the mortality with NHH patients were investigated by conducting univariate and multivariate logistic regression analyses. A nomogram to predict the risk of hospital mortality was constructed. Receiver operating characteristic curve (ROC) analysis was conducted to compare nomogram (ammonia into a prognostic model, P1) with the simplified acute physiology II (SAPSII) and quick sequential organ failure assessment (qSOFA). Five independent factors for the mortality in patients with NHH were identified, including age, platelets, bun, hemoglobin, and ammonia. Models P1 using ammonia showed good prediction power. The AUROC of P1 (AUROC, 0.755 [95% CI, 0.713–0.796]) was higher than that of qSOFA (AUROC, 0.500 [95% CI, 0.449–0.551]), and SAPS II (AUROC, 0.703[95% CI, 0.658–0.748]). Ammonia was an independent prognostic predictor of mortality for NHH patients. We developed a nomogram that can predict hospital mortality with patients. Nomogram had superior discriminative power to qSOFA and SAPS II, indicating that the nomogram may have clinical utility.
format Online
Article
Text
id pubmed-7837986
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-78379862021-01-28 Analysis of clinical prognosis in patients with non-hepatic hyperammonemia Li, Yun Zhou, Qi Song, Jian-Nan Chen, Xue-Zhao Zhang, Xi-Zhe Sun, Yi Medicine (Baltimore) 3900 The aim of this study was to evaluate the association of non-hepatic hyperammonemia (NHH) with the prognosis of critically ill patients with NHH. According to the serum ammonia level, the patients with NHH (n = 498) were retrieved by us. The risk factors of the mortality with NHH patients were investigated by conducting univariate and multivariate logistic regression analyses. A nomogram to predict the risk of hospital mortality was constructed. Receiver operating characteristic curve (ROC) analysis was conducted to compare nomogram (ammonia into a prognostic model, P1) with the simplified acute physiology II (SAPSII) and quick sequential organ failure assessment (qSOFA). Five independent factors for the mortality in patients with NHH were identified, including age, platelets, bun, hemoglobin, and ammonia. Models P1 using ammonia showed good prediction power. The AUROC of P1 (AUROC, 0.755 [95% CI, 0.713–0.796]) was higher than that of qSOFA (AUROC, 0.500 [95% CI, 0.449–0.551]), and SAPS II (AUROC, 0.703[95% CI, 0.658–0.748]). Ammonia was an independent prognostic predictor of mortality for NHH patients. We developed a nomogram that can predict hospital mortality with patients. Nomogram had superior discriminative power to qSOFA and SAPS II, indicating that the nomogram may have clinical utility. Lippincott Williams & Wilkins 2021-01-22 /pmc/articles/PMC7837986/ /pubmed/33546031 http://dx.doi.org/10.1097/MD.0000000000024157 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 3900
Li, Yun
Zhou, Qi
Song, Jian-Nan
Chen, Xue-Zhao
Zhang, Xi-Zhe
Sun, Yi
Analysis of clinical prognosis in patients with non-hepatic hyperammonemia
title Analysis of clinical prognosis in patients with non-hepatic hyperammonemia
title_full Analysis of clinical prognosis in patients with non-hepatic hyperammonemia
title_fullStr Analysis of clinical prognosis in patients with non-hepatic hyperammonemia
title_full_unstemmed Analysis of clinical prognosis in patients with non-hepatic hyperammonemia
title_short Analysis of clinical prognosis in patients with non-hepatic hyperammonemia
title_sort analysis of clinical prognosis in patients with non-hepatic hyperammonemia
topic 3900
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837986/
https://www.ncbi.nlm.nih.gov/pubmed/33546031
http://dx.doi.org/10.1097/MD.0000000000024157
work_keys_str_mv AT liyun analysisofclinicalprognosisinpatientswithnonhepatichyperammonemia
AT zhouqi analysisofclinicalprognosisinpatientswithnonhepatichyperammonemia
AT songjiannan analysisofclinicalprognosisinpatientswithnonhepatichyperammonemia
AT chenxuezhao analysisofclinicalprognosisinpatientswithnonhepatichyperammonemia
AT zhangxizhe analysisofclinicalprognosisinpatientswithnonhepatichyperammonemia
AT sunyi analysisofclinicalprognosisinpatientswithnonhepatichyperammonemia